相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Erythrocytes as carriers of immunoglobulin-based therapeutics
Weihang Ji et al.
ACTA BIOMATERIALIA (2020)
Targeting Strategies for Tissue-Specific Drug Delivery
Zongmin Zhao et al.
CELL (2020)
Surface-anchored framework for generating RhD-epitope stealth red blood cells
Yueqi Zhao et al.
SCIENCE ADVANCES (2020)
Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems
Patrick M. Glassman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis
Zongmin Zhao et al.
SCIENCE ADVANCES (2019)
Use of Population Pharmacokinetic Analyses Among FDA-Approved Biologics
Ken Ogasawara et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
Jacob S. Brenner et al.
NATURE COMMUNICATIONS (2018)
The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity
H. Luke Anderson et al.
JOURNAL OF IMMUNOLOGY (2018)
Biocompatible coupling of therapeutic fusion proteins to human erythrocytes
Carlos H. Villa et al.
BLOOD ADVANCES (2018)
Pathways of protein and lipid receptor-mediated transcytosis in drug delivery
Roland Thuenauer et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Immunogenicity of murine mPEG-red blood cells and the risk of anti-PEG antibodies in human blood donors
Yevgeniya Le et al.
EXPERIMENTAL HEMATOLOGY (2017)
Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury
Ronald Carnemolla et al.
FASEB JOURNAL (2017)
Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes
Peter Popp Wibroe et al.
NATURE NANOTECHNOLOGY (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease
Novalia Pishesha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond
Carlos H. Villa et al.
TRANSFUSION MEDICINE REVIEWS (2017)
From the Cradle to the Grave: The Role of Macrophages in erythropoiesis and erythrophagocytosis
Thomas R. L. Klei et al.
FRONTIERS IN IMMUNOLOGY (2017)
Nanomedicines: From Bench to Bedside and Beyond
Henry Havel et al.
AAPS JOURNAL (2016)
Drug-loaded erythrocytes: on the road toward marketing approval
Vanessa Bourgeaux et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches
Aaron C. Anselmo et al.
BIOMATERIALS (2015)
Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition
Shaojun Shi et al.
CURRENT DRUG METABOLISM (2015)
Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes
Prabhani U. Atukorale et al.
NANOSCALE (2015)
Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens
Alizee J. Grimm et al.
SCIENTIFIC REPORTS (2015)
Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase
Kristen M. Lorentz et al.
SCIENCE ADVANCES (2015)
Approaches to erythrocyte-mediated drug delivery
Mauro Magnani et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application
Huining He et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes
Rajesh Mukthavaram et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes
Jiahai Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Distearoyl Anchor-Painted Erythrocytes with Prolonged Ligand Retention and Circulation Properties In Vivo
Guixin Shi et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells
Aaron C. Anselmo et al.
ACS NANO (2013)
Advanced drug delivery systems for antithrombotic agents
Colin F. Greineder et al.
BLOOD (2013)
Human erythrocytes as drug carriers: Loading efficiency and side effects of hypotonic dialysis, chlorpromazine treatment and fusion with liposomes
M. E. Favretto et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice
Nelson S. Yew et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Engineering antigens for in situ erythrocyte binding induces T-cell deletion
Stephan Kontos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cells
Rafi Chapanian et al.
BIOMATERIALS (2012)
In vivo circulation, clearance, and biodistribution of polyglycerol grafted functional red blood cells
Rafi Chapanian et al.
BIOMATERIALS (2012)
Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis
Sergei Zaitsev et al.
BLOOD (2012)
Microthrombosis after experimental subarachnoid hemorrhage: Time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan
Jared M. Pisapia et al.
EXPERIMENTAL NEUROLOGY (2012)
Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent
Kathryn C. Gersh et al.
BLOOD (2011)
Red blood cell-coupled tissue plasminogen activator prevents impairment of cerebral vasodilatory responses through inhibition of c-Jun-N-terminal kinase and potentiation of p38 mitogen-activated protein kinase after cerebral photothrombosis in the newborn pig
William M. Armstead et al.
PEDIATRIC CRITICAL CARE MEDICINE (2011)
Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation
Sergei Zaitsev et al.
BLOOD (2010)
Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites
Guo-Ping Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders
William M. Armstead et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis
Sergei Zaitzev et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics
K. C. Gersh et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Improving Protein Pharmacokinetics by Engineering Erythrocyte Affinity
Stephan Kontos et al.
MOLECULAR PHARMACEUTICS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability
Hemant Sarin
VASCULAR CELL (2010)
Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes
Elsa Briones et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers
Sheng-Hua Yuan et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Red blood cells-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia/ischemia through inhibition of ERK MAPK activation
William M. Armstead et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile
Juan-Carlos Murciano et al.
JOURNAL OF CONTROLLED RELEASE (2009)
L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL)
Young Min Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Erythrocyte-Bound Tissue Plasminogen Activator is Neuroprotective in Experimental Traumatic Brain Injury
Sherman C. Stein et al.
JOURNAL OF NEUROTRAUMA (2009)
Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator
Kristina Danielyan et al.
CIRCULATION (2008)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes
Carmen Gutierrez Millan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia
Rong Deng et al.
BLOOD (2007)
Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes
Oleksii A. Skorokhod et al.
HAEMATOLOGICA (2007)
The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition
Kumkum Ganguly et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation
Sanjay Khandelwal et al.
TRANSFUSION (2007)
Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis
Sergei Zaitsev et al.
BLOOD (2006)
Fibrin affinity of erythrocyte-coupled tissue-type plasminogen activators endures hemodynamic forces and enhances fibrinolysis in vivo
K Ganguly et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The erythrocyte viral trap: Transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection
DR Asher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pharmacology of estrogens and progestogens: influence of different routes of administration
H Kuhl
CLIMACTERIC (2005)
Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients - A pilot uncontrolled study
V Annese et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Blood clearance and activity of erythrocyte-coupled fibrinolytics
K Ganguly et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients
L Rossi et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes
JC Murciano et al.
NATURE BIOTECHNOLOGY (2003)
Carrier erythrocytes: An overview
M Hamidi et al.
DRUG DELIVERY (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease
L Rossi et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2001)
Mouse erythrocytes as carriers for coencapsulated alcohol and aldehyde dehydrogenase obtained by electroporation -: In vivo survival rate in circulation, organ distribution and ethanol degradation
C Lizano et al.
LIFE SCIENCES (2001)
Polyethylene glycol-coated red blood cells fail to bind glycophorin A -: Specific antibodies and are impervious to invasion by the Plasmodium falciparum malaria parasite
DP Blackall et al.
BLOOD (2001)
In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase
BE Bax et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Clinical pharmacokinetics of transdermal opioids - Focus on transdermal fentanyl
S Grond et al.
CLINICAL PHARMACOKINETICS (2000)
分享论文
